Author details

Full Name

Zhiguang Li

Affiliation

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37205123	TLSEA: a tool for lncRNA set enrichment analysis based on multi-source heterogeneous information fusion.		2023
36531225	Prediction of potential small molecule-miRNA associations based on heterogeneous network representation learning.		2022
35697682	A proteogenomic signature of age-related macular degeneration in blood.	Nat Commun	2022
34525956	A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer.	BMC Cancer	2021
33846644	Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.	Nat Biotechnol	2021
34092242	A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).	Cancer Cell International	2021
33863366	A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.	Genome Biol	2021
33863344	Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.	Genome Biol	2021
32859993	Oncogenic AURKA-enhanced N-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells.	Cell Research	2021
34446004	Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD).	Cancer Cell International	2021
34763648	Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.	BMC Cancer	2021
33015045	miR-146a-5p Plays an Oncogenic Role in NSCLC via Suppression of TRAF6.	Frontiers in Cell and Developmental Biology	2020
31786363	Longitudinal whole-genome sequencing reveals the evolution of MPAL.	Cancer genetics	2020
32928372	Expression of miR-34a is a sensitive biomarker for exposure to genotoxic agents in human lymphoblastoid TK6 cells.	Mutation Research - Genetic Toxicology and Environmental Mutagenesis	2020
31480291	High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 Study.	Cancers	2019
30919951	Using plasma cell-free DNA to monitor the chemoradiotherapy course of cervical cancer.	International Journal of Cancer	2019
31077131	pTrimmer: An efficient tool to trim primers of multiplex deep sequencing data.	BMC Bioinformatics	2019
30799199	The prognostic landscape of interactive biological processes presents treatment responses in cancer.	eBioMedicine	2019
31369215	Targeted deep sequencing from multiple sources demonstrates increased NOTCH1 alterations in lung cancer patient plasma.	Cancer Medicine	2019
29442836	Facile Hydrothermal Synthesis and Enhanced Methane Sensing Properties of Pt-Decorated ZnO Nanosheets.	Journal of Nanoscience and Nanotechnology (discontinued)	2018
30076202	Spatial Vulnerabilities of the Genome to Spontaneous Mutations Revealed with Improved Duplex Sequencing.	Genetics	2018
30009687	Conflicts of CpG density and DNA methylation are proximally and distally involved in gene regulation in human and mouse tissues.	Epigenetics	2018
29907586	YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity.	Cancer Discovery	2018
30231942	Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells.	Cancer Communications	2018
27493194	Detection of differentially methylated regions in whole genome bisulfite sequencing data using local Getis-Ord statistics.		2016
26918340	Systematic characterization of lncRNAs' cell-to-cell expression heterogeneity in glioblastoma cells.	Oncotarget	2016
27474172	Clonal evolution of acute myeloid leukemia highlighted by latest genome sequencing studies.	Oncotarget	2016
26243830	Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks.	IET Systems Biology	2015
25952319	Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid.	BMC Genomics	2015
26032981	Distinct roles of DNMT1-dependent and DNMT1-independent methylation patterns in the genome of mouse embryonic stem cells.		2015
25106556	Tissue-specific microRNA responses in rats treated with mutagenic and carcinogenic doses of aristolochic acid.	Mutagenesis	2014
25260323	Surface wrinkling and cracking dynamics in the drying of colloidal droplets.	European Physical Journal E	2014
23973223	The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3.	Immunity	2013
21976715	MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver.	Mutagenesis	2012
22470567	Discovery of novel microRNAs in rat kidney using next generation sequencing and microarray validation.	PLoS ONE	2012
22130878	Functional comparison of microarray data across multiple platforms using the method of percentage of overlapping functions.	Methods in Molecular Biology	2012
21866971	Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells.	ACS Nano	2011
22297810	Increased expression of miR-34a in mouse spleen one day after exposure to N-ethyl-N-nitrosourea.	Journal of Applied Toxicology	2011
21370286	MicroRNAs and their predicted target messenger RNAs are deregulated by exposure to a carcinogenic dose of comfrey in rat liver.	Environmental and Molecular Mutagenesis	2011
21143388	Nanostructural materials increase mineralization in bone cells and affect gene expression through miRNA regulation.	Journal of Cellular and Molecular Medicine	2011
21834575	Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys.	Chem Res Toxicol	2011
20145547	A myeloid cell population induced by Freund adjuvant suppresses T-cell-mediated antitumor immunity.	Journal of Immunotherapy	2010
21029445	Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxic carcinogen N-ethyl-N-nitrosourea.	BMC Genomics	2010
20676074	The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.	Nat Biotechnol	2010
20175128	A potential microRNA signature for tumorigenic conazoles in mouse liver.	Molecular Carcinogenesis	2010
20410929	Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression.	Gene Therapy	2010
19811677	Microarray platform consistency is revealed by biologically functional analysis of gene expression profiles.	BMC Bioinformatics	2009
19244111	IFNgamma promotes papilloma development by up-regulating Th17-associated inflammation.	Cancer Research	2009
20003817	Paradoxical roles of IL-4 in tumor immunity.	Cellular and Molecular Immunology	2009
18974110	Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis.	Cancer Research	2008